Skip to content
10-Q

Quarterly Report

89bio, Inc.

0000950170-25-062836

← back to feed
Filed
May 2, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 25, 2025 145.98M sh
Shares Diluted Q1 2025 · Mar 31, 2025 146.37M sh
Shares Diluted Q1 2025 · Mar 31, 2024 95.85M sh
Capex Q1 2025 · Mar 31, 2025 $72K
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$71.74M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$39.72M
Long Term Debt Q1 2025 · Mar 31, 2025 $35.94M
Long Term Debt Q1 2025 · Dec 31, 2024 $35.73M
Short Term Debt Q1 2025 · Mar 31, 2025 $0
Cash And Equivalents Q1 2025 · Mar 31, 2025 $315.4M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $126.06M
Stockholders Equity Q1 2025 · Mar 31, 2025 $605.46M
Stockholders Equity Q1 2025 · Dec 31, 2024 $400.79M
Stockholders Equity Q1 2025 · Mar 31, 2024 $510.54M
Stockholders Equity Q1 2025 · Dec 31, 2023 $536.31M
Current Liabilities Q1 2025 · Mar 31, 2025 $37.88M
Current Liabilities Q1 2025 · Dec 31, 2024 $36.13M
Total Liabilities Q1 2025 · Mar 31, 2025 $79.57M
Total Liabilities Q1 2025 · Dec 31, 2024 $77.9M
Current Assets Q1 2025 · Mar 31, 2025 $682.94M
Current Assets Q1 2025 · Dec 31, 2024 $476.45M
Total Assets Q1 2025 · Mar 31, 2025 $685.03M
Total Assets Q1 2025 · Dec 31, 2024 $478.69M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.49
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.54
Eps Basic Q1 2025 · Mar 31, 2025 −$0.49
Eps Basic Q1 2025 · Mar 31, 2024 −$0.54
Sga Expense Q1 2025 · Mar 31, 2025 $11.52M
Sga Expense Q1 2025 · Mar 31, 2024 $9.85M
Rd Expense Q1 2025 · Mar 31, 2025 $64.39M
Rd Expense Q1 2025 · Mar 31, 2024 $47.43M
Net Income Q1 2025 · Mar 31, 2025 −$71.28M
Net Income Q1 2025 · Mar 31, 2024 −$51.68M
Operating Income Q1 2025 · Mar 31, 2025 −$75.91M
Operating Income Q1 2025 · Mar 31, 2024 −$57.28M